¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"anterior sinus group"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • anterior tibial artery
    ¾ÕÁ¤°­µ¿¸Æ, Àü°æ°ñµ¿¸Æ
  • anterior tibial compartment syndrome
    Á¾¾Æ¸®¾ÕÄ­ÁõÈıº, ¾ÕÁ¤°­±¸È¹ÁõÈıº
  • anterior trapezoid nucleus
    ¾Õ¸¶¸§¼¶À¯Ã¼ÇÙ, Àü´ÉÇüüÇÙ
  • anterior triangle of neck
    ¾Õ¸ñ»ï°¢
  • anterior uveitis
    ¾ÕÆ÷µµ¸·¿°, ÀüÆ÷µµ¸·¿°
  • anterior ventral nucleus
    ¾Õ¹èÂÊÇÙ, Àüº¹ÃøÇÙ
  • serratus anterior muscle
    ¾ÕÅé´Ï±Ù, Àü¹æ°Å±Ù
  • atomic group
    ¿øÀÚ´Ü
  • ABO blood group system
    ABOÇ÷¾×Çüü°è
  • amino group
    ¾Æ¹Ì³ë±â
  • basic food group
    ±âÃʽÄǰ±º
  • blood group
    Ç÷¾×Çü
  • blood group incompatibility
    Ç÷¾×ÇüºÎÀûÇÕ
  • blood group system
    Ç÷¾×Çüü°è
  • coliform group
    ´ëÀå±Õ±º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • group-specific antigen
    ±ºÆ¯ÀÌÇ׿ø
  • basic food group
    ±âÃʽÄǰ±º
  • blood group
    Ç÷¾×Çü
  • blood group incompatibility
    Ç÷¾×ÇüºÎÀûÇÕ
  • blood group system
    Ç÷¾×Çü±º
  • blood group specific substance
    Ç÷¾×ÇüƯÀ̹°Áú
  • borderline group
    °æ°è±º
  • coliform group
    ´ëÀå±Õ±º
  • complementation group
    »óº¸¼ºÁý´Ü
  • complementophil group
    º¸Ã¼Ä£È­±â
  • control group
    ´ëÁ¶±º
  • determinant group
    °áÁ¤±º
  • diagnosis related group
    À¯»çÁø´Ü±ºÀÇ·áºñÁöºÒ¹ý
  • didactic group therapy
    ±³À°Áý´Ü¿ä¹ý
  • directive group therapy
    Áö½ÃÁý´Ü¿ä¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hypersensitive carotid sinus
    °ú¹Î¼º °æµ¿¸Æµ¿(¡­ ÔÑØæ÷Ó).
  • inferior petrosal sinus
    ¾Æ·¡¾Ï¼®Á¤¸Æµ¿, ÇÏÃßüÁ¤¸Æµ¿(ù»õÞô÷ð¡ØæÔÑ).
  • inferior petrosal sinus
    ¾Æ·¡¹ÙÀ§Á¤¸Æµ¿±¼
  • inferior sagittal sinus
    ¾Æ·¡½Ã»óÁ¤¸Æµ¿, ÇϽûóÁ¤¸Æµ¿(ù»ãÅßÒð¡ØæÔÑ).
  • inferior sagittal sinus
    ¾Æ·¡½Ã»óÁ¤¸Æµ¿±¼
  • petrosal sinus
    ÃßüÁ¤¸Æµ¿.
  • petrosquamous sinus
    ÃßüÀλóüµ¿ (¡­ô÷÷Ó).
  • phasic sinus arrhythmia
    »ó¼ºµ¿ºÎÁ¤¸Æ(ßÓàõ÷ÓÝÕïÚØæ).
  • pilonidal sinus
    ÅеÕÁöµ¿±¼
  • pilonidal sinus
    ¸ð¼Ò·ç(Ù¾áµ×ª)
  • pilonidal sinus
    ¸ð¼Ò·ç(Ù¾áµ×ª)
  • posterior sinus
    µÚµ¿±¼
  • preauricular sinus
    ±Ó¹ÙÄû¾Õµ¿±¼
  • primitive urogenital sinus
    ¿ø½Ãºñ´¢»ý½Äµ¿, ¿ø½Ã´¢»ý½Äµ¿(ê«ã·èñßæãÖ÷Ó).
  • primitive urogenital sinus
    ¿ø½Ãºñ´¢»ý½Äµ¿±¼
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • complementophil group
    º¸Ã¼Ä£È­±â.
  • control group
    ´ëÁ¶±º(ÓßðÎÏÛ)
  • control group
    ´ëÁ¶±º(ËÀ̡˴).
  • determinant group
    °áÁ¤±º(¡­ÏØ).
  • diagnosis related group(DRG)
    Áø´Ü¸íº° ±º, À¯»çÇÑ Áø´Ü¸íµé³¢¸® ¹­¾î À̸¦ ´ÜÀ§·Î ÀÇ·áºñ¸¦ ÁöºÒÇÏ´Â ¹æ¹ý
  • diagnostic related group
    Áø´Ü°ü·Ã±º
  • didactic group therapy
    ±³À°Àû Áý´Ü¿ä¹ý
  • directive group therapy
    Áö½Ã¼º Áý´Ü¿ä¹ý
  • discrepancy in ABO blood group
    ABO Ç÷¾×ÇüºÒÀÏÄ¡
  • end group
    ¸»´Ü±â.
  • enteric group
    Àå°è¼¼±Õ±º, Àå³»¼¼±Õ±º
  • evocative group therapy
    Ç¥ÇöÀû Áý´Ü¿ä¹ý(øúúÞîÜó¢Ó¥ÖûÛö)
  • frontal group of aphasia
    ÀüµÎ¿±½Ç¾î±º(¡­ã÷åÞÏØ).
  • functional group
    ÀÛ¿ë±â(íÂéÄÐñ).
  • glucophore group
    ´ã´ç±â.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Transverse sinus
    ½ÉÀ帷°¡·Îµ¿±¼
    [¿¾ ¿ë¾î] ½É¸·È¾µ¿
  • Coronary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] °ü»óÁ¤¸Æµ¿
  • Coronary sinus (partial)
    ½ÉÀåÁ¤¸Æµ¿±¼(ºÎºÐ)
    [¿¾ ¿ë¾î] °ü»óÁ¤¸Æµ¿
  • Orifice of coronary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼±¸¸Û
    [¿¾ ¿ë¾î] ½ÉÀåÁ¤¸Æµ¿±¸
  • Valve of conary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼ÆÇ¸·
    [¿¾ ¿ë¾î] °ü»óÁ¤¸Æµ¿ÆÇ
  • Valve of coronary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼ÆÇ¸·
    [¿¾ ¿ë¾î] °ü»óÁ¤¸ÆÆÇ
  • Inferior petrosal sinus
    ¾Æ·¡¹ÙÀ§Á¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] ÇÏÃßüÁ¤¸Æµ¿
  • Groove for inferior petrosal sinus
    ¾Æ·¡¹ÙÀ§Á¤¸Æµ¿±¼°í¶û
    [¿¾ ¿ë¾î] ÇÏÃßüµ¿±¸
  • Inferior sagittal sinus
    ¾Æ·¡½Ã»óÁ¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] ÇϽûóÁ¤¸Æµ¿
  • Definitive urogenital sinus
    ¿Ï¼ººñ´¢»ý½Äµ¿±¼
    [¿¾ ¿ë¾î] ¿Ï¼º¿ä»ý½Äµ¿
  • Primitive urogenital sinus
    ¿ø½Ãºñ´¢»ý½Äµ¿±¼
    [¿¾ ¿ë¾î] ¿ø½Ã¿ä»ý½Äµ¿
  • Superior petrosal sinus
    À§¹ÙÀ§Á¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] »óÃßüÁ¤¸Æµ¿
  • Groove for superior petrosal sinus
    À§¹ÙÀ§Á¤¸Æµ¿±¼°í¶û
    [¿¾ ¿ë¾î] »óÃßüµ¿±¸
  • Superior sagittal sinus
    À§½Ã»óÁ¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] »ó½Ã»óÁ¤¸Æµ¿
  • Groove for superior sagittal sinus
    À§½Ã»óÁ¤¸Æµ¿±¼°í¶û
    [¿¾ ¿ë¾î] »ó½Ã»óµ¿±¸
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • glycoloyl group
    ±Û¶óÀÌÄÚ·ÎÀϱâ(Ðñ)
  • glycolyl group
    ±Û¶óÀÌÄÚ¸±±â(Ðñ)
  • glycosyl group
    ±Û¶óÀÌÄڽDZâ(Ðñ)
  • Gm group
    Gm ±â(Ðñ)
  • group specificity
    ±â(Ðñ) ƯÀ̼º(÷åì¶àõ)
  • group transfer reaction
    ¿øÀÚ´Ü ÀüÀÌ ¹ÝÀÀ(ê«í­Ó¥ï®ì¹Úãëë)
  • group transfer potential
    ¿øÀÚ´Ü ÀüÀÌ ÀüÀ§(ê«í­Ó¥ï®ì¹Úãëë)
  • group translocation
    ¹«¸® ÀüÀ§(ï®êÈ)
  • guanidinium group
    ±¸¾Æ´Ïµð´Ï¿ò±â(Ðñ)
  • guanidino group
    ±¸¾Æ´Ïµð³ë±â(Ðñ)
  • guanido group
    ±¸¾Æ´Ïµµ±â(Ðñ)
  • haptenic group
    ÇÕÅÙ±â(Ðñ)
  • high-mobility group
    °íÀ̵¿µµ ±º(ÍÔì¹ÔÑÓøÏØ)
  • hydroxyl group
    ÇÏÀ̵å·Ï½Ç±â(Ðñ)
  • hydroxymethyl group
    ÇÏÀ̵å·Ï½Ã¸ÞÆ¿±â(Ðñ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • anterior auricular nerves
    ÀüÀ̰³½Å°æ
  • anterior axillary line
    Àü¾×¿Í¼±
  • anterior belly
    Àüº¹
  • anterior cerebral artery
    Àü´ë³úµ¿¸Æ
  • anterior chamber
    Àü¹æ
  • anterior choroidal artery
    Àü¸Æ¶ôÃѵ¿¸Æ
  • anterior circumflex humeral artery
    ¾Õ»ó¿ÏÈÖµ¹À̵¿¸Æ, Àü»ó¿Ïȸ¼±µ¿¸Æ
  • anterior clinoid process
    Àü»óµ¹±â
  • anterior commissure
    Àü±³·Ã
  • anterior communicationg artery
    ¾Õ±³Å뵿¸Æ, Àü±³Å뵿¸Æ
  • anterior cranial fossa
    ÀüµÎ°³¿Í
  • anterior cruciate ligament
    Àü½ÊÀÚÀδë
  • anterior cusp
    Àü÷
  • anterior descending artery
    ÀüÇÏÇൿ¸Æ
  • anterior ethmoidal artery
    Àü»ç°ñµ¿¸Æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CCG Children's Cancer Study Group; cholecystogram, cholecystography; clinically coherent group
DRG diagnosis-related group; Division of Research Grants [NIH}; dorsal respiratory group; dorsal root ga...
GS gallstone; Gardner syndrome; gastric shield; general surgery; gestational score; Gilbert syndrome; g...
GT gait training; galactosyl transferase; gastrostomy; generation time; genetic therapy; gingiva treatm...
MN a blood group in the MNSs blood group system; malignant nephrosclerosis; Master of Nursing; meganewt...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
group II group I
Group III group
CSS Carotid Sinus Syndrome
CSH Carotid sinus hypersensitivity
CSM Carotid sinus massage
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • carotid sinus massage
    °æµ¿¸Æµ¿ ¸¶»çÁö
  • carotid sinus reflex
    °æµ¿¸Æµ¿ ¹Ý»ç
  • carotid sinus syndrome
    °æµ¿¸Æµ¿ ÁõÈıº
  • cartoid sinus syndrome
    °æµ¿¸Æµ¿ ÁõÈıº
  • carvernous sinus
    ÇØ¸é Á¤¸Æµ¿
  • cavenous sinus
    ÇØ¸é Á¤¸Æµ¿
    µÎ°³°ñÀÇ Á¢Çü°ñ°ú ÁöÁÖ¸· »çÀÌ µÎ³úÀú ÇϹ濡 À§Ä¡ÇÏ´Â ÇÑ ½ÖÀÇ ¾çÃø¼º Á¤¸Æ±¸ Áß Çϳª.
  • cavernous sinus
    ÇØ¸é Á¤¸Æµ¿
  • cavernous sinus thrombosis
    ÇØ¸é Á¤¸Æµ¿ Ç÷Àü, ÇØ¸é Á¤¸Æµ¿ Ç÷ÀüÁõ, µÎ°³³»µ¿ÀÇ Ç÷Àü
    ¾È±¸ µ¹ÃâÁõ, °á¸· ºÎÁ¾, ±¤¼± °øÆ÷Áõ, À¯·ç°¡ ³ªÅ¸³ª¸ç Ä¡¸íÀûÀÌ´Ù.
  • cervical sinus
    °æµ¿
  • cranial sinus
    °æ¸· Á¤¸Æµ¿
  • dural sinus thrombosis
    °æ¸·µ¿ Ç÷ÀüÁõ
  • dural venous sinus
    °æÁú¸· Á¤¸Æµ¿, °æ¸· Á¤¸Æµ¿
  • empyema of maxillary sinus
    »ó¾Çµ¿ Ãà³óÁõ
  • endoaermal sinus tumor
    ³»¹è¿±µ¿ Á¾¾ç
    ¹ß»ý ºóµµ°¡ ³·Áö¸¸ ³­¼ÒÀÇ ¾Ç¼º »ý½Ä ¼¼Æ÷Á¾ Áß¿¡ µÎ ¹øÂ°·Î ÈçÇϰí Àüü ³­¼Ò Á¾¾çÀÇ 1% Á¤µµ¸¦ Â÷ÁöÇÑ´Ù. Á¶Á÷ÇÐÀûÀ¸·Î ³­È² ³¶ÀÇ ³»¹è¿± µ¿À» ´à¾Ò´Ù ÇÏ¿© ³­È² ³­ Á¾¾ç ¶Ç´Â ³»¹è¿±µ¿ Á¾¾çÀ̶ó°í ÇÑ´Ù. ÀÌ Á¾¾çÀº ÁÖ·Î ¾î¸°ÀÌ¿Í ÀþÀº ¿©¼º¿¡ È£¹ßÇÏ°í Æò±Õ ¿¬·ÉÀº 19¼¼ÀÌ´Ù. Çö¹Ì°æÀûÀ¸·Î ÀÛÀº ´Ù¹æ¼º ³¶ ±¸Á¶¸¦ °®´Â °íÇü¼º Á¾¾çÀÌ°í ´ë°³ ÀÏÃø¼ºÀÌ´Ù. ¾û¼ºÇÑ ¸Á»óÇü ¾ç»ó, Schiller-¿·¹Ì ¼Òü¸¦ Çü¼ºÇÏ´Â À¯µÎ ¾ç»ó, ´Ù¼Ò ³¶Æ÷¼º ³­È² ¾ç»ó, °íÇü¼º ¾ç»ó µîÀÌ È¥ÇÕµÇ¾î ³ª¿À°í ±¸¼º ¼¼Æ÷´Â ¹Ì¼º¼÷ ¹è ¼¼Æ÷ÀÇ Æ¯Â¡À» °®´Â´Ù. ¼¼Æ÷Áú ¾ÈÀ̳ª ¼¼Æ÷ ¹Û¿¡ À¯¸®Áú ±¸»óüµéÀÌ °üÂûµÇ´Âµ¥ À̵éÀº ¸é¿ª È¿¼Ò ¿°»ö¿¡¼­ ¾ËÆÄ ÅÂ¾Æ ´Ü¹é
  • ethmoid sinus
    »ç°ñ µ¿
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
Rhesus blood group <haematology> Human blood group system with allelic red cell antigens C, D and E.
The D antigen is the strongest. Red cells from a Rhesus positive foetus cross the placenta and can sensitise a Rehesus negative mother, expecially at parturition. The mother's antibody may then, in a subsequent pregnancy, cause haemolytic disease of the newborn if the foetus is Rhesus positive.
The disease can be prevented by giving antiD IgG during the first 72 hours after parturition to mop up D red cells in the maternal circulation. 1st ed
(18 Nov 1997)
rh-hr blood-group system Erythrocyte isoantigens of the rh (rhesus) blood group system, the most complex of all human blood groups, because the genes differ by determining a different number of the over thirty antigens thus far described and do so with remarkably different quality. The major antigen rh or d is the most common cause of erythroblastosis foetalis.
(12 Dec 1998)
chlorine group The halogens.
(05 Mar 2000)
group 1. A cluster, crowd, or throng; an assemblage, either of persons or things, collected without any regular form or arrangement; as, a group of men or of trees; a group of isles.
2. An assemblage of objects in a certain order or relation, or having some resemblance or common characteristic; as, groups of strata.
3. <biology> A variously limited assemblage of animals or planta, having some resemblance, or common characteristics in form or structure. The term has different uses, and may be made to include certain species of a genus, or a whole genus, or certain genera, or even several orders.
4. A number of eighth, sixteenth, etc, notes joined at the stems; sometimes rather indefinitely applied to any ornament made up of a few short notes.
Origin: F groupe, It. Gruppo, groppo, cluster, bunch, packet, group; of G. Origin: cf. G. Krepf craw, crop, tumour, bunch. See Crop.
Source: Websters Dictionary
(01 Mar 1998)
group agglutination Agglutination by antibodies specific for minor (group) antigens common to several microorganisms, each of which possesses its own major specific antigen.
Synonym: cross agglutination.
(05 Mar 2000)
group agglutinin An immune agglutinin specific for a group antigen.
Synonym: cross-reacting agglutinin.
(05 Mar 2000)
group antigens Antigen's that are shared by related genera of microorganisms.
(05 Mar 2000)
group A streptococcal necrotizing fasciitis A complication of infection with GAS (group A streptococci) in which the bacteria attacks and destroys muscle tissue. According to the CDC, 5-10% of people with severe GAS infection develop necrotizing fasciitis. Though the infection can be treated with antibiotics, the fatality rate is close to 30%. This complication often develops as a wound infection after surgery or injury.
(05 Mar 2000)
group A streptococci A common bacteria that is the cause of strep throat, scarlet fever, impetigo, cellulitis-erysipelas, rheumatic fever, acute glomerular nephritis, endocarditis, and group A streptococcal necrotizing fasciitis. The prototype is Streptococcus pyogenes.
(05 Mar 2000)
group B streptococci A leading cause of a form of neonatal sepsis that has a 10-20% mortality rate and leaves a large number of survivors with brain damage. Also a leading cause of meningitis.
(05 Mar 2000)
group dynamics A term used to represent the study of underlying features of group behaviour, e.g., motives, attitudes; it is concerned with group change rather than with static characteristics.
(05 Mar 2000)
group homes Housing for groups of patients, children, or others who need or desire emotional or physical support. They are usually established as planned, single housekeeping units in residential dwellings that provide care and supervision for small groups of residents, who, although unrelated, live together as a family.
(12 Dec 1998)
group hospital A private hospital organised and controlled by a group of physicians and restricted to the reception and care of their own patients.
(05 Mar 2000)
group III mycobacteria Mycobacteria that are either colourless or that slowly produce a light yellow pigment when grown in the presence of light. Organisms placed in this group belong to the species Mycobacterium intracellulare.
Synonym: nonchromogens.
(05 Mar 2000)
group II mycobacteria Mycobacteria that produce a yellow pigment even when grown in the dark; when grown in the light, the pigment is orange. These organisms behave as do saprophytes in humans and are nonpathogenic to laboratory animals.
Synonym: scotochromogens.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • group therapy
    Áý´Ü ¿ä¹ý
  • group velocity
    (ÆÄµ¿ÀÇ)±º¼Óµµ
  • group work
    Áý´Ü(»çȸ)»ç¾÷
  • habitat group
    »ýÅ·ù(¼­½Ä ȯ°æÀ» °°ÀÌ ÇÏ´Â µ¿½Ä¹°);(¹Ú¹°°ü¿¡ Àü½ÃµÈ)»ý¹° ȯ°æ ¸ðÇü
  • income group
    »çȸ ¼ÒµæÃþ(µ¿ÀÏ ¼Òµæ¼¼¾×Áý´Ü)
  • informal group
    (»çȸ)ºñ°ø½ÄÀû Áý´Ü(°üû°øÀåµî¿¡¼­ÀÇ)
  • interested group
    (»çȸ)ÀÌÀͰøµ¿Ã¼;°øÅëÀÌÇØ´Üü(±¹°¡ Á¤´çŬ·´µî)
  • minority group
    ¼Ò¼ö¹ÎÁ·(Çѳª¶óÀÇ)
  • peer group
    µ¿·á Áý´Ü;µ¿¹è Áý´Ü
  • pressure group
    ¾Ð·Â ´Üü
  • primary group
    Á¦ ÀÏÂ÷ Áý´Ü(°¡Á¤,Ä£±¸ µî)
  • rape group
    ÅäÀÇ(Åä·Ð)±×·ì
  • reference group
    ÁذŠÁý´Ü(°³ÀÎÀÌ ÀÚ±â ŵµ.ÆÇ´ÜÀÇ ±âÁØÀ¸·Î ¿©±â´Â ƯÁ¤ Áý´Ü)
  • splinter group
    ºÐÆÄ;¼Ò¼öÆÄ
  • tail group
    TAIL UNIT
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á